Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Identification of a novel mutation gene signature HAMP for cholangiocarcinoma through comprehensive TCGA and GEO data mining
Zhengguang Wang, Yaqi Du
International Immunopharmacology (2021) Vol. 99, pp. 108039-108039
Closed Access | Times Cited: 12

Showing 12 citing articles:

The Role of Iron in Cancer Progression
Qianqian Guo, Liwen Li, Shanshan Hou, et al.
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 96
ScRNA-seq and bulk RNA-seq reveal the characteristics of ferroptosis and establish a risk signature in cholangiocarcinoma
Wenchao Yao, Xuxu Liu, Yuanhang He, et al.
Molecular Therapy — Oncolytics (2022) Vol. 27, pp. 48-60
Open Access | Times Cited: 13
Downregulation of dermatopontin in cholangiocarcinoma cells suppresses CCL19 secretion of macrophages and immune infiltration
Peng Xu, Siyang Li, Ke Liu, et al.
Journal of Cancer Research and Clinical Oncology (2024) Vol. 150, Iss. 2
Open Access | Times Cited: 2
Prognostic biomarker HAMP and associates with immune infiltration in gastric cancer
Jing Yang, Hui Wei, Mengxiao Liu, et al.
International Immunopharmacology (2022) Vol. 108, pp. 108839-108839
Closed Access | Times Cited: 7
Identification of molecular subtypes based on bile acid metabolism in cholangiocarcinoma
Mingxia Deng, Jing Liu, Li Zhang, et al.
BMC Cancer (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 1
HAMP as a Potential Diagnostic, PD-(L)1 Immunotherapy Sensitivity and Prognostic Biomarker in Hepatocellular Carcinoma
Guo-Ming Chen, Cheng Zhang, Danyun Li, et al.
Biomolecules (2023) Vol. 13, Iss. 2, pp. 360-360
Open Access | Times Cited: 3
Identification of cell senescence molecular subtypes in prediction of the prognosis and immunotherapy of hepatitis B virus-related hepatocellular carcinoma
Yu Xue, Peng Chen, Wei Yi, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 4
High Hepcidin expression predicts poor prognosis in patients with clear cell renal cell carcinoma
Yuting Tang, Shengdong Ge, Xiao Zheng, et al.
Diagnostic Pathology (2022) Vol. 17, Iss. 1
Open Access | Times Cited: 4
Development and validation of a gene expression-based nomogram to predict the prognosis of patients with cholangiocarcinoma
Wei Wang, Chen Wu, Lijun Xu, et al.
Journal of Cancer Research and Clinical Oncology (2023) Vol. 149, Iss. 12, pp. 9577-9586
Open Access | Times Cited: 1
Hepcidin: A multifaceted hormone in iron homeostasis and tumor biology
Xiaoyu Liu, Xinyu Zhang, Yumei Fan, et al.
Vitamins and hormones (2024)
Closed Access
Hepcidin as a prognostic biomarker in clear cell renal cell carcinoma.
Zijian Zhou, Jiajin Wu, Yuanyuan Yang, et al.
PubMed (2022) Vol. 12, Iss. 9, pp. 4120-4139
Closed Access | Times Cited: 2
Functional analysis of differently expressed ferroptosis-related genes in patients with mitral valve prolapse
Hui Xie, Liushun Wang, Yihu Tang, et al.
Frontiers in Genetics (2022) Vol. 13
Open Access | Times Cited: 1
Page 1

Scroll to top